Presentation is loading. Please wait.

Presentation is loading. Please wait.

Figure 3 Birt–Hogg–Dubé (BHD) renal tumour histology

Published byAbigail Gray Modified over 6 years ago

Similar presentations

Presentation on theme: "Figure 3 Birt–Hogg–Dubé (BHD) renal tumour histology"— Presentation transcript:

1 Figure 3 Birt–Hogg–Dubé (BHD) renal tumour histology
Figure 3 | Birt–Hogg–Dubé (BHD) renal tumour histology. a | Hybrid oncocytic tumour; ×150 magnification. b | Chromophobe renal tumour with characteristic perinuclear halos; ×150 magnification. c | Clear cell renal tumour. d | Renal oncocytoma in a BHD patient; ×150 magnification. e | Renal oncocytosis in normal kidney parenchyma of a BHD patient; ×100 magnification. Images are provided courtesy of Dr Maria J. Merino, Laboratory of Pathology, National Cancer Institute, National Institutes of Health. Images are provided courtesy of Dr Maria J. Merino, Laboratory of Pathology, National Cancer Institute, National Institutes of Health Schmidt, L. S. & Linehan, W. M. (2015) Molecular genetics and clinical features of Birt–Hogg–Dubé syndrome Nat. Rev. Urol. doi: /nrurol

Download ppt "Figure 3 Birt–Hogg–Dubé (BHD) renal tumour histology"

Similar presentations

© 2009 NHS National Genetics Education and Development CentreGenetics and Genomics for Healthcare www.geneticseducation.nhs.uk Turner Syndrome Clinical.

© 2009 NHS National Genetics Education and Development CentreGenetics and Genomics for Healthcare Turner Syndrome Clinical.
Regional Perspectives on Renal Cell Carcinoma Mohamed Abdulla M.D. Professor of Clinical Oncology Cairo University AfME. September 17 th 2010W: www.oncologyclinic.org.

Regional Perspectives on Renal Cell Carcinoma Mohamed Abdulla M.D. Professor of Clinical Oncology Cairo University AfME. September 17 th 2010W:
NEW APPROACHES IN CANCER PATHOLOGY - LESSONS FROM RENAL CARCINOMA STEWART FLEMING UNIVERSITY OF DUNDEE.

NEW APPROACHES IN CANCER PATHOLOGY - LESSONS FROM RENAL CARCINOMA STEWART FLEMING UNIVERSITY OF DUNDEE.
Management of T1 Kidney Cancer Laparoscopic Surgery

Management of T1 Kidney Cancer Laparoscopic Surgery
Data from The Johns Hopkins Renal Mass Registry

Data from The Johns Hopkins Renal Mass Registry
Kidney Cancer Like other cancers, kidney or “renal cell” cancer has a family history in 4% of the cases. Familial kidney cancers, like sporadic cases,

Kidney Cancer Like other cancers, kidney or “renal cell” cancer has a family history in 4% of the cases. Familial kidney cancers, like sporadic cases,
Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol
Figure 1 Number of somatic mutation rates across The Cancer Genome Atlas (TCGA) projects Figure 1 | Number of somatic mutation rates across The Cancer.

Figure 1 Number of somatic mutation rates across The Cancer Genome Atlas (TCGA) projects Figure 1 | Number of somatic mutation rates across The Cancer.
Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol
Normal kidney This fat is normal.

Normal kidney This fat is normal.
Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol
Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol
Figure 2 Recruitment of experts to the Delphi study

Figure 2 Recruitment of experts to the Delphi study
Figure 1 The UMBRELLA SIOP-RTSG 2016 protocol logo

Figure 1 The UMBRELLA SIOP-RTSG 2016 protocol logo
Figure 2 Multiscale modelling in oncology

Figure 2 Multiscale modelling in oncology
Figure 1 Cellular processes involved in cancer development

Figure 1 Cellular processes involved in cancer development
Figure 5 Schematic illustration of different clinical trial designs

Figure 5 Schematic illustration of different clinical trial designs
Nat. Rev. Urol. doi: /nrurol

Nat. Rev. Urol. doi: /nrurol
Figure 3 Semantic model of the active surveillance (AS) timeline

Figure 3 Semantic model of the active surveillance (AS) timeline
Figure 1 Postulated mechanisms of action of PD‑1, PD‑L1 and PD‑L2

Figure 1 Postulated mechanisms of action of PD‑1, PD‑L1 and PD‑L2

Similar presentations

Ads by Google